United Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Amarin USD 58.77M 56.06M 2025-03
Ardelyx USD 108M 12M 2024-12
Baxter International USD 2.54B 29M 2025-06
Bayer EUR 10.73B 688M 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Halozyme Therapeutics USD 123.28M 48K 2025-06
Insmed USD 361.29M 20.33M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
J&J USD 16.8B 8.54B 2025-06
Moderna USD 1.04B 113M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Teva Pharmaceutical Industries USD 3.28B 95M 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


United Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.